A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

with the company saying that the test was significantly more accurate than CA19-9, the biomarker commonly used to detect pancreatic cancer. Additionally, Immunovia has said that its new test opens ...

OHSU researchers discovered a new blood test that identifies pancreatic cancer early on with 85% accuracy when done alongside the current CA 19-9 test.